Advanced Blood-Brain Barrier Opening Systems for Enhanced Drug Delivery
Legal Citation
Summary of the Inventive Concept
A next-generation system for selectively opening the blood-brain barrier, leveraging cutting-edge technologies such as transcranial magnetic stimulation, low-intensity ultrasound, artificial intelligence, multimodal imaging, optogenetics, and nanorobots to revolutionize drug delivery to the brain.
Background and Problem Solved
The original patent disclosed an ultrasound-guided system for opening the blood-brain barrier. However, this approach has limitations, including the need for precise positioning and potential side effects. The new inventive concept addresses these limitations by introducing novel, synergistic technologies that enable more targeted, efficient, and safe blood-brain barrier opening.
Detailed Description of the Inventive Concept
The advanced blood-brain barrier opening system comprises multiple modules, including transcranial magnetic stimulation, low-intensity ultrasound, and optogenetics. The system utilizes artificial intelligence and multimodal imaging data to generate a personalized brain atlas, identifying target regions for blood-brain barrier opening. The system then applies a combination of focused ultrasound and optogenetics to selectively open the blood-brain barrier in the target region. Additionally, the system features a wearable ultrasound transducer array, a neural signal processing unit, and a machine learning algorithm to predict optimal ultrasound parameters for personalized blood-brain barrier opening. The system can be operated in a closed-loop mode, where real-time imaging feedback adjusts ultrasound parameters to optimize blood-brain barrier opening. Furthermore, the system can be integrated with nanorobot technology, enabling targeted and precise blood-brain barrier opening.
Novelty and Inventive Step
The new inventive concept introduces a paradigm shift in blood-brain barrier opening by combining synergistic technologies, such as transcranial magnetic stimulation, low-intensity ultrasound, and optogenetics, to achieve enhanced drug delivery. The use of artificial intelligence, multimodal imaging, and machine learning algorithms to personalize and optimize blood-brain barrier opening is a significant departure from the original patent's approach.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include the use of different ultrasound frequencies, pulse durations, or intensities. Additionally, the system could be adapted for use in different brain regions or for treating various brain diseases. Variations of the system could also incorporate other technologies, such as electrical stimulation or gene therapy, to further enhance blood-brain barrier opening.
Potential Commercial Applications and Market
The advanced blood-brain barrier opening system has significant commercial potential in the pharmaceutical and biotechnology industries, enabling more effective and targeted drug delivery to the brain. The system could be used to treat a range of brain diseases, including brain cancers, Alzheimer's disease, and Parkinson's disease, addressing a large and growing market.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Biomedical engineering, medical device technologies, focused ultrasound systems for neurological interventions, with expertise in medical imaging, signal processing, and targeted drug delivery techniques
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or medical device researcher with advanced degrees in bioengineering, electrical engineering, or medical physics, possessing knowledge of ultrasound technologies, neuroimaging, and blood-brain barrier modulation techniques
Obviousness Rationale
A person having ordinary skill in the art would recognize that the published technical disclosure represents predictable variations and technological extensions of the source patent's ultrasound-based blood-brain barrier opening system. The PTD introduces additional modalities and control mechanisms that are logical technological progressions from the foundational ultrasound transducer approach described in the original patent. These variations represent incremental improvements using known techniques in neural interface technologies and personalized medical interventions.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,812 |
|---|---|
| Title | Ultrasound guided opening of blood-brain barrier |
| Assignee(s) | Cordance Medical Inc. |